We’re excited to participate in the 10th anniversary of the Innate Killer Summit! On March 4th, don’t miss Kanya Rajangam, MD, PhD, President and Head of R&D and Chief Medical Officer, as she chairs Day 1, where she will be presenting our initial clinical trial results from SENTI-202-101 in R/R AML and chairs the Industry Leaders’ fireside chat on Advancements & Challenges in the Natural Killer Space and Brian Garrison, PhD, Vice President of Research, for his presentation on Incorporating Gene Circuits & Synthetic Biology into Next-Generation Allogeneic Cell Therapies. We hope to see you there!
Way to go, Kanya and Brian!